Biological drugs mostly differ from classical agents in their molecular mass, complex three-dimensional structure, molecular heterogeneity and imunogenity. Moreover, the most important aspect of these agents is their capability of targeting specific signal molecules, consequently\u00a0causing no or less damage to the non-targeted tissue. Hence, this fact led to widely accepted belief that biopharmaceutical drugs are among the safest on the market. During the conduct of different studies researchers found new physiological roles of targeted molecules that\u00a0were previously unknown. These findings overruled the assumption about targeted therapy\u00a0being selective and specific and made the researchers question their safety. Over the last two\u00a0decades, there has been an exponential growth of investments into the development of new\u00a0molecular therapies. Hence, there are a lot of studies underway and more targeted biologic\u00a0drugs registered every year.<\/p>\n","protected":false},"excerpt":{"rendered":"
Biological drugs mostly differ from classical agents in their molecular mass, complex three-dimensional structure, molecular heterogeneity and imunogenity. Moreover, the most important aspect of these agents is their capability of targeting specific signal molecules, consequently\u00a0causing no or less damage to the non-targeted tissue. Hence, this fact led to widely accepted belief that biopharmaceutical drugs are […]<\/p>\n","protected":false},"author":43,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[399,436,418],"tags":[],"class_list":["post-7395","post","type-post","status-publish","format-standard","hentry","category-2-2012-archive","category-oncology","category-pharmacology-and-experimental-toxicology"],"acf":[],"yoast_head":"\n